Pier Paolo Pandolfi

This inventor holds 16 USPTO granted patents and 9 published patent applications and 3 EPO patents. Top assignees: Memorial Sloan Kettering Cancer Center, Beth Israel Deaconess Medical Center, Inc., Aalborg University. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pier Paolo Pandolfi. Retrieved from https://idiyas.com/inventor/pier-paolo-pandolfi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 9)

% Patents Active = 87.5

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 96(Granted Patents)

Location History:

New York, NY (US) (2001 - 2012)
Boston, MA (US) (2017 - 2023)

Company Filing History:

8 out of 621

Memorial Sloan Kettering Cancer Center

patents

7 out of 539

Beth Israel Deaconess Medical Center, Inc.

Sloan-Kettering Institute for Cancer Research

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691135 - INHIBITORS OF MICRO-RNA 22 (2026-07-28),

2. 11753639 - Micro-RNA and obesity (2023-09-12),

3. 11499152 - Inhibitors of micro-RNA 22 (2022-11-15),

4. 11274301 - Micro-RNA inhibitors and their uses in disease (2022-03-15),

5. 10443055 - Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer (2019-10-15),

6. 10131905 - Micro-RNA inhibitors and their uses in disease (2018-11-20),

7. 9822358 - Treatment of cancers with micro-RNA inhibitors (2017-11-21),

8. 8273379 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2012-09-25),

9. 7879364 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2011-02-01),

10. 6982096 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2006-01-03),

11. 6884439 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2005-04-26),

12. 6861076 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2005-03-01),

13. 6855339 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2005-02-15),

14. 6770304 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2004-08-03),

15. 6723351 - Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol (2004-04-20),

Title: The Innovative Journey of Pier Paolo Pandolfi

Introduction

Pier Paolo Pandolfi is a prominent inventor based in Boston, Massachusetts, recognized for his contributions to the field of medical research. With a total of six patents to his name, he has made significant advancements in understanding and treating metabolic disorders, particularly through innovative methods involving microRNAs.

Latest Patents

Among his latest inventions, Pandolfi has focused on methods to treat or prevent metabolic disorders by using agents that inhibit microRNAs modulating metabolism. One of his notable patents is centered around micro-RNA and obesity, which outlines a novel approach to addressing this widespread health concern. Another significant patent involves inhibitors of micro-RNA 22, providing valuable techniques to inhibit specific microRNAs and thus influence metabolic processes.

Career Highlights

Pandolfi has had a distinguished career, with key positions at prestigious institutions such as Beth Israel Deaconess Medical Center and Aalborg University. His work at these organizations has facilitated breakthroughs in biological research, enhancing the understanding of gene regulation and its implications for human health.

Collaborations

Throughout his career, Pier Paolo Pandolfi has collaborated with notable professionals in the field, including coworkers Yvonne Tay and Laura Poliseno. Their collective expertise has significantly contributed to advancing research projects and fostering innovative solutions in medical science.

Conclusion

In conclusion, Pier Paolo Pandolfi's impact as an inventor is underscored by his significant contributions to medical research and patent innovations. His dedication to understanding metabolic disorders through the lens of microRNAs showcases the potential for targeted therapies to improve health outcomes for individuals affected by such conditions. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.